Literature DB >> 32553331

Clinical Outcomes Following Coronary Bifurcation PCI Techniques: A Systematic Review and Network Meta-Analysis Comprising 5,711 Patients.

Giuseppe Di Gioia1, Jeroen Sonck1, Miroslaw Ferenc2, Shao-Liang Chen3, Iginio Colaiori4, Emanuele Gallinoro4, Takuya Mizukami5, Monika Kodeboina1, Sakura Nagumo5, Danilo Franco6, Jozef Bartunek4, Marc Vanderheyden4, Eric Wyffels4, Bernard De Bruyne4, Jens F Lassen7, Johan Bennett8, Dobrin Vassilev9, Patrick W Serruys10, Goran Stankovic11, Yves Louvard12, Emanuele Barbato6, Carlos Collet13.   

Abstract

OBJECTIVES: The aim of this study was to compare clinical outcomes of different bifurcation percutaneous coronary intervention (PCI) techniques.
BACKGROUND: Despite several randomized trials, the optimal PCI technique for bifurcation lesions remains a matter of debate. Provisional stenting has been recommended as the default technique for most bifurcation lesions. Emerging data support double-kissing crush (DK-crush) as a 2-stent technique.
METHODS: PubMed and Scopus were searched for randomized controlled trials comparing PCI bifurcation techniques for coronary bifurcation lesions. Outcomes of interest were major adverse cardiovascular events (MACE). Secondary outcomes of interest were cardiac death, myocardial infarction, target vessel or lesion revascularization, and stent thrombosis. Summary odds ratios (ORs) were estimated using Bayesian network meta-analysis.
RESULTS: Twenty-one randomized controlled trials including 5,711 patients treated using 5 bifurcation PCI techniques were included. Investigated techniques were provisional stenting, T stenting/T and protrusion, crush, culotte, and DK-crush. Median follow-up duration was 12 months (interquartile range: 9 to 36 months). When all techniques were considered, patients treated using the DK-crush technique had less occurrence of MACE (OR: 0.39; 95% credible interval: 0.26 to 0.55) compared with those treated using provisional stenting, driven by a reduction in target lesion revascularization (OR: 0.36; 95% credible interval: 0.22 to 0.57). No differences were found in cardiac death, myocardial infarction, or stent thrombosis among analyzed PCI techniques. No differences in MACE were observed among provisional stenting, culotte, T stenting/T and protrusion, and crush. In non-left main bifurcations, DK-crush reduced MACE (OR: 0.42; 95% credible interval: 0.24 to 0.66).
CONCLUSIONS: In this network meta-analysis, DK-crush was associated with fewer MACE, driven by lower rates of repeat revascularization, whereas no significant differences among techniques were observed for cardiac death, myocardial infarction, and stent thrombosis. A clinical benefit of 2-stent techniques was observed over provisional stenting in bifurcation with side branch lesion length ≥10 mm.
Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  bifurcation techniques; coronary bifurcations; network meta-analysis

Year:  2020        PMID: 32553331     DOI: 10.1016/j.jcin.2020.03.054

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  10 in total

1.  Stenting left main disease: all roads lead to Rome: Stenting left main disease.

Authors:  Shao-Liang Chen
Journal:  AsiaIntervention       Date:  2021-12

2.  Practice Patterns in the Interventional Treatment of Coronary Bifurcation Lesions: A Global Survey.

Authors:  Ilias Nikolakopoulos; Evangelia Vemmou; Judit Karacsonyi; Lorenzo Azzalini; Brian A Bergmark; Yiannis S Chatzizisis; Allison B Hall; Jason Wollmuth; Kevin Croce; Hani Jneid; Bavana V Rangan; M Nicholas Burke; Emmanouil S Brilakis
Journal:  J Invasive Cardiol       Date:  2022-01       Impact factor: 2.022

Review 3.  Systematic Review and Network Meta-Analysis Comparing Bifurcation Techniques for Percutaneous Coronary Intervention.

Authors:  Dae Yong Park; Seokyung An; Neeraj Jolly; Steve Attanasio; Neha Yadav; Sunil Rao; Aviral Vij
Journal:  J Am Heart Assoc       Date:  2022-06-20       Impact factor: 6.106

Review 4.  [Bifurcation lesions : Are new strategies and devices needed?]

Authors:  Luise Gaede
Journal:  Herz       Date:  2022-10-21       Impact factor: 1.740

5.  Double kissing inflation outside the stent secures the patency of small side branch without rewiring.

Authors:  Hongbo Yang; Yanan Song; Jiatian Cao; Xueyi Weng; Feng Zhang; Yuxiang Dai; Hao Lu; Chenguang Li; Zheyong Huang; Juying Qian; Junbo Ge
Journal:  BMC Cardiovasc Disord       Date:  2021-05-07       Impact factor: 2.298

6.  Randomized non-inferiority TrIal comParing reverse T And Protrusion versus double-kissing and crush Stenting for the treatment of complex left main bifurcation lesions.

Authors:  Maximilian Olschewski; Helen Ullrich; Maike Knorr; Giulio Makmur; Majid Ahoopai; Thomas Münzel; Tommaso Gori
Journal:  Clin Res Cardiol       Date:  2021-11-24       Impact factor: 6.138

7.  Optical Coherence Tomography to Assess Proximal Side Optimization Technique in Crush Stenting.

Authors:  Francesco Lavarra; Giuseppe Tarantini; Davide Sala; Vasile Sirbu
Journal:  Front Cardiovasc Med       Date:  2022-03-15

Review 8.  Fundamentals of percutaneous coronary bifurcation interventions.

Authors:  Tamer Kırat
Journal:  World J Cardiol       Date:  2022-03-26

9.  Clinical Outcomes of Percutaneous Coronary Intervention for Bifurcation Lesions According to Medina Classification.

Authors:  Mohamed O Mohamed; Pablo Lamellas; Ariel Roguin; Rohit M Oemrawsingh; Alexander J J Ijsselmuiden; Helen Routledge; Frank van Leeuwen; Roxane Debrus; Marco Roffi; Mamas A Mamas
Journal:  J Am Heart Assoc       Date:  2022-08-24       Impact factor: 6.106

10.  Effect of Stenting Strategy on the Outcome in Patients with Non-Left Main Bifurcation Lesions.

Authors:  Yongwhan Lim; Min Chul Kim; Youngkeun Ahn; Doo Sun Sim; Young Joon Hong; Ju Han Kim; Myung Ho Jeong; Hyeon-Cheol Gwon; Hyo-Soo Kim; Seung Woon Rha; Jung Han Yoon; Yangsoo Jang; Seung-Jea Tahk; Ki Bae Seung
Journal:  J Clin Med       Date:  2022-09-26       Impact factor: 4.964

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.